T. Rowe Price Associates, Inc. 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-10 5:19 pm Purchase | 2024-08-31 | 13G | Tenax Therapeutics, Inc. TENX | T. Rowe Price Associates, Inc. | 3,750,000 19.990% | 3,750,000 (New Position) | Filing |